US Stock MarketDetailed Quotes

SNDX Syndax Pharmaceuticals

Watchlist
  • 13.240
  • -0.390-2.86%
Close Dec 18 16:00 ET
1.13BMarket Cap-3.64P/E (TTM)

Syndax Pharmaceuticals Key Stats

Syndax Pharmaceuticals Q3 2024 Earnings Date

Currency:USDNov 5, 2024

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Revenue
8.40M
12.50M
+4.10M
Beat Est.
--
--
+48.83%
EPS
-1.03
-0.98
+0.05
Beat Est.
-40.72%
-34.25%
+4.59%
Strong Buy

Dec 18, 2024

Syndax Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 16.142M--
--2024/Q4-- / 115.892M--
Nov 5, 20242024/Q312.500M / 8.399M--
Aug 1, 20242024/Q23.500M / 0.000--
May 8, 20242024/Q10.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 16.142M--
--2024/Q4-- / 115.892M--
Nov 5, 20242024/Q312.500M / 8.399M--
Aug 1, 20242024/Q23.500M / 0.000--
May 8, 20242024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Syndax Pharmaceuticals Earnings Reports

Read more

Trending US Stocks
Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

Analysis

Analyst Rating

Updated: Dec 18, 2024

Strong Buy

  • Buy

    92.86%
  • Hold

    7.14%
  • Sell

    0.00%

Price Target

No Data